Search

Objective：To investigate the effect of Irisin on the endometrial function in obese rats. Methods：Female SD rats were treated with high-fat diets to induce obesity, while the normal-control group (n=16) was treated with normal diets. The obese rats were randomly divided into the model-control group (n=16) and the irisin group (n=16). The rats in the irisin group were injected intraperitoneally with recombinant irisin [100 ng/（g· d）×14 days], while the rats in the two control groups were injected with normal saline. Then, female rats in estrus were mated with male rats. Eight rats were sacrificed in each group on the day 5 and day 10 of pregnancy. The pregnancy rate, average number of blastocyst and embryo morphology were observed. The expressions of leukemia inhibitory factor (LIF) and integrin αvβ3 in the implantation sites were determined. Results：The body weight in the irisin group after treatment was significantly lower than that in the model-control group (P=0.035), and the average number of blastocyst in the model-control group were significantly lower than that in the irisin group and the normal-control group (both P＜0.05). The endometrium of the normal-control group was full, and the embryo was well developed. The uterine cavity in the model-control group was large, and the embryonic development was poor. The endometrium of the irisin group was closed, and the embryonic development was well improved. The expression levels of LIF and integrin αvβ3 mRNAs and proteins in the model-control group were significantly lower than those in the normal-control group and the irisin group (all P＜0.05). Conclusions：Irisin can improve the endometrial receptivity of obese rats by increasing the expressions of LIF and integrin αvβ3 in endometrium. [ABSTRACT FROM AUTHOR]

Objective: Irisin is a factor related to insulin sensitivity. In this study, the level of serum Irisin was measured in patients with polycystic ovary syndrome (PCOS), and its significance was discussed. Methods: Eighty patients with PCOS (the PCOS group) and 60 healthy women (the control group) with regular menstrual cycle were included in our center from July 2014 to February 2016. PCOS patients were then divided into two subgroups: obese and non-obese groups, according to the body mass index (BMI). After physical examination, serum lipids, sex hormones and irisin level were measured, and compared between groups. Results: ① The levels of irisin, testosterone (T), luteinizing hormone (LH), total cholesterol (TC), BMI and waist-to-hip ratio (WHR) in the PCOS group were significantly higher than those in the control group, while the levels of high density lipoprotein cholesterol (HDL-c) and Estradiol (E2) were significantly lower (all P＜0.05). In patients with PCOS after excluding other indexes, there was a significant positive correlation between serum irisin level and T or BMI （r=0.476, P＜0.001; r=0.329, P=0.041, respectively）. ②The level of TG in the obese PCOS subgroup was higher than that in the non-obese PCOS subgroup （P=0.028）. However, the level of irisin in the obese PCOS subgroup was slightly higher than that in the non-obese PCOS subgroup, without significant difference （P=0.087）. Conclusions: The level of serum irisin in PCOS patients was significantly increased, and positively correlated with androgen and BMI, suggesting that irisin may be a factor related to PCOS. [ABSTRACT FROM AUTHOR]